Table 5. Estimated SARS-CoV-2 seroprevalence, by reported experience of COVID-19 symptoms, Dublin and Sligo, Ireland, 22 June–16 July 2020 (n = 33).

COVID-19 symptom level	Dublin			Sligo
	Seropositive (n = 28)	Weighted prevalence (%)	95% CI	Seropositive (n = 5)	Weighted prevalence (%)	95% CI
Asymptomatic	2	0.55	0.06–2.01	1	0.19	0.003–1.16
Paucisymptomatica	5	2.71	0.86–6.31	1	0.57	0.01–3.13
Consistent with case definitionb	21	7.40	4.55–11.25	3	1.54	0.30–4.53

COVID-19: coronavirus disease; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

^a Individuals who reported at least one symptom but whose symptom(s) was not consistent with the Irish case definition for COVID-19 of the time (Table 1).

^b Individuals who reported one of the following: fever, cough, shortness of breath, loss sense of smell or taste.

Missing values were regarded as negative for the symptom except for participants for whom no symptom data were available, who were excluded.